Additional Information

Description

Orencia 125 mg/mL is a subcutaneous injectable biologic medication used for the treatment of autoimmune disorders, including rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis. It contains abatacept, a selective T-cell co-stimulation modulator that inhibits immune system overactivity, reducing inflammation and joint damage.

The active ingredient, abatacept, functions by binding to CD80 and CD86 receptors on antigen-presenting cells, preventing the activation of T-cells. The 125 mg/mL formulation is administered via a prefilled syringe, ensuring precise dosing and ease of use for patients requiring long-term immunosuppressive therapy.

Orencia is designed for weekly subcutaneous administration, providing a consistent and sustained therapeutic effect. It is supplied in a ready-to-use device that eliminates the need for manual preparation. Patients are advised to inject it in the thigh, abdomen, or upper arm, rotating sites to minimize injection site reactions.

.